Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antitumor activity of thalidomide in refractory multiple myeloma.

Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med. 1999 Nov 18; 341(21):1565-71.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.